$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] Antibiotic resistance in Gram-positive cocci

International journal of antimicrobial agents, v.16 no.4, 2000년, pp.473 - 478  

Jeljaszewicz, J (National Institute of Hygiene, Medical University of Warsaw, 24 Chocimska, 00-791 Warsaw, Poland) ,  Mlynarczyk, G (Department of Medical Microbiology, Medical University of Warsaw, Warsaw, Poland) ,  Mlynarczyk, A (Department of Medical Microbiology, Medical University of Warsaw, Warsaw, Poland)

Abstract AI-Helper 아이콘AI-Helper

AbstractGram-positive cocci still predominate as a cause of nosocomial- and community-acquired infections. These organisms frequently reveal a high natural, intrinsic resistance to antimicrobials. Additionally, these bacteria are able to acquire resistance to frequently used drugs rapidly through se...

주제어

참고문헌 (42)

  1. Blok. Operacyjny. Jeljaszewicz 3-4 49 1998 Current threats of antibiotic resistance in bacteria 

  2. Zentbl. Bakteriol. Mlynarczyk 287 277 1998 10.1016/S0934-8840(98)80165-5 Genome in Staphylococcus aureus: a review 

  3. Gene Domanski 167 111 1995 10.1016/0378-1119(96)82965-9 Analysis of Staphylococcus aureus genes encoding penicillin-binding protein 4 and an ABC-type transporter 

  4. Antimicrob. Agents Chemother. Henze 40 2121 1996 10.1128/AAC.40.9.2121 Penicillin-binding protein 4 overproduction increases beta-lactam resistance in Staphylococcus aureus 

  5. Berger-Bachi 158 1997 The Staphylococci in Human Disease Resistance not mediated by beta-lactamase (methicillin resistance) 

  6. Chemotherapy Berger-Bachi 42 19 1996 10.1159/000239498 Update on methicillin resistance mechanisms in staphylococci 

  7. Mol. Gen. Genet. Berger-Bachi 219 263 1989 10.1007/BF00261186 femA, A best-mediated factor essential for methicillin resistance in Staphylococcus aureus: molecular cloning and characterization 

  8. Microb. Drug Resist. Kopp 2 29 1996 10.1089/mdr.1996.2.29 Staphylococcal peptidoglycan interpeptide bridge biosynthesis: a novel antistaphylococcal target? 

  9. FEMS Microbiol. Lett. Tschierske 153 261 1997 10.1111/j.1574-6968.1997.tb12583.x Lif, the lysostaphin immunity factor, complements FemB in staphylococcal peptidoglycan interpeptide bridge formation 

  10. J. Bacteriol. Henze 175 1612 1993 10.1128/jb.175.6.1612-1620.1993 Influence of femB on methicillin resistance and peptidoglycan metabolism in Staphylococcus aureus 

  11. J. Biol. Chem. Omelas-Soares 268 26268 1993 10.1016/S0021-9258(19)74310-5 The peptidoglycan composition of a Staphylococcus aureus mutant selected for reduced methicillin resistance 

  12. J. Biol. Chem. Omelas-Soares 269 27246 1994 10.1016/S0021-9258(18)46975-X Reduced methicillin resistance in a new Staphylococcus aureus transposon mutant that incorporates muramyl dipeptides into the cell wall peptidoglycan 

  13. Microb. Drug Res. Wu 5 9 1999 10.1089/mdr.1999.5.9 Mrp a new auxiliary gene essential for optimal expression of methicillin resistance in Staphylococcus aureus 

  14. Eur. J. Clin. Microbiol. Infect. Dis. Voss 13 50 1994 10.1007/BF02026127 Methicillin-resistant Staphylococcus aureus in Europe 

  15. J. Hosp. Infect. Mlynarczyk 34 151 1996 10.1016/S0195-6701(96)90141-3 Epidemiology of methcillin resistant Staphylococcus aureus in a Warsaw hospital 

  16. Antimicrob. Agents Chemother. Chow 41 3 511 1997 10.1128/AAC.41.3.511 A novel gentamicin resistance gene in Enterococcus 

  17. Res. Microbiol. Courvalin 150 367 1999 10.1016/S0923-2508(99)80071-0 Combinatorial approach of bacteria to antibiotic resistance 

  18. Microb. Drug Res. Fontana 2 2 209 1996 10.1089/mdr.1996.2.209 Intrinsic penicillin resistance in enterococci 

  19. J. Bacteriol. Zorzi 178 16 4948 1996 10.1128/jb.178.16.4948-4957.1996 Structure of the low-affinity penicillin-binding protein 5 PBP5 in wild-type and highly penicillin-resistant strains of Enterococcus faecium 

  20. Clin. Microbiol. Rev. Woodford 8 585 1995 10.1128/CMR.8.4.585 Current perspectives on glycopeptide resistance 

  21. Antimicrob. Agents Chemother. Perichon 41 2016 1997 10.1128/AAC.41.9.2016 VanD-type glycopeptide-resistant Enterococcus faecalis BM4339 

  22. Eur. J. Clin. Microbiol. Infect. Dis. Reynolds 8 943 1989 10.1007/BF01967563 Structure, biochemistry and mechanism of action of glycopeptide antibiotics 

  23. Gene Arthur 154 87 1995 10.1016/0378-1119(94)00851-I The vanZ gene of Tn1546 from Enterococcus faecalis BM4147 confers resistance to teicoplanin 

  24. J. Bacteriol. Arthur 179 97 1997 10.1128/jb.179.1.97-106.1997 The VanS sensor negatively controls VanR-mediated transcriptional activation of glycopeptide resistance genes of Tn1546 and related elements in the absence of induction 

  25. Mol. Microbiol. Baptista 32 1 17 1999 10.1046/j.1365-2958.1999.01308.x Single-cell analysis of glycopeptide resistance gene expression in teicoplanin-resistant mutants of a VanB-type Enterococcus faecalis 

  26. J. Bacteriol. Casadewall 181 3644 1999 10.1128/JB.181.12.3644-3648.1999 Characterization of the vanD glycopeptide resistance gene cluster from Enterococcus faecium BM4339 

  27. Gene Quintiliani 172 1 1996 10.1016/0378-1119(96)00110-2 Characterization of Tn1547, a composite transposon flanked by the IS16 and IS256-like elements, that confers vancomycin resistance in Enterococcus faecalis BM4281 

  28. Gene Dudka-Malen 112 53 1992 10.1016/0378-1119(92)90302-6 Sequence of the vanC gene of Enterococcus gallinarum BM4174 encoding a d-alanine:d-alanine ligase-related protein necessary for vancomycin resistance 

  29. Antimicrob. Agents Chemother. Navarro 38 101 1994 10.1128/AAC.38.8.1788 Analysis of genes encoding d-alanine-d-alanine ligase-related enzymes in Enterococcus casseliflavus and Enterococcus flavescens 

  30. Mol. Microbiol. Arias 31 1653 1999 10.1046/j.1365-2958.1999.01294.x Characterization and modelling of VanT: a novel, membrane bound, serine racemase form vancomycin-resistant Enterococcus galinarum BM4174 

  31. Antimicrob. Agents Chemother. Fines 43 2161 1999 10.1128/AAC.43.9.2161 VanE, a new type of acquired glycopeptide resistance in Enterococcus faecalis BM4405 

  32. J. Antimicrob. Chemother. Hiramatsu 40 135 1997 10.1093/jac/40.1.135 Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility 

  33. Lancet Hiramatsu 350 1670 1997 10.1016/S0140-6736(97)07324-8 Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin 

  34. Antimicrob. Agents Chemother. Milewski 40 166 1996 10.1128/AAC.40.1.166 Overproduction of a 37-kilodalton cytoplasmatic protein homologous to NAD+-linked d-lactate dehydrogenase associated with vancomycin resistance in Staphylococcus aureus 

  35. J. Bacteriol. Boyle-Vavra 179 6756 1997 10.1128/jb.179.21.6756-6763.1997 Cloning of the Staphylococcus aureus ddh gene encoding NAD+-dependent D-lactate dehydrogenase and insertional inactivation in a glycopeptide-resistant isolate 

  36. J. Bacteriol. Billot-Klein 179 4684 1997 10.1128/jb.179.15.4684-4688.1997 Presence of UDP-N-acetylmuramyl-hexapeptides and heptapeptides in enterococci and staphylococci after treatment with ramoplanin, tunicamycin or vancomycin 

  37. J. Bacteriol. Sieradzki 179 2557 1997 10.1128/jb.179.8.2557-2566.1997 Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus 

  38. Antimicrob. Agents. Chemother. Sieradzki 42 100 1998 10.1128/AAC.42.1.100 Decreased susceptibilities to teicoplanin and vancomycin among coagulase-negative methicillin-resistant clinical isolates of staphylococci 

  39. J. Antimicrob. Chemother. Mlynarczyk 39 136 1997 10.1093/jac/40.1.136 Lysogenic conversion as a factor influencing the vancomycin tolerance phenomenon in Staphylococcus aureus 

  40. J. Antimicrob. Chemother. May 42 189 1998 10.1093/jac/42.2.189 Glycopeptide tolerance in Staphylococcus aureus 

  41. Med. Dosw. Mikrobiol. Mlynarczyk 47 141 1995 Bacteriophages of the serologic group B converting synthesis of fibrinolysin in Staphylococcus aureus 

  42. Med. Dosw. Mikrobiol. Mlynarczyk 47 149 1995 Bacteriophages of the serologic group F converting synthesis of fibrinolysin and beta toxin in Staphylococcus aureus 

관련 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로